Figure 2From: Beyond KRAS mutation status: influence of KRAScopy number status and microRNAs on clinical outcome to cetuximab in metastatic colorectal cancer patients Box plots of the expression levels of miR-181a, miR-200b and miR-143 in mCRC patients according to clinical outcome and KRAS mutation status. Abbreviations: G = good responders, P = poor responders, MT = mutant, WT = wild-type.Back to article page